Green Alpha Advisors, LLC Arcturus Therapeutics Holdings Inc. Transaction History
Green Alpha Advisors, LLC
- $86 Million
- Q4 2025
A detailed history of Green Alpha Advisors, LLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Green Alpha Advisors, LLC holds 28,282 shares of ARCT stock, worth $205,610. This represents 0.24% of its overall portfolio holdings.
Number of Shares
28,282
Previous 21,443
31.89%
Holding current value
$205,610
Previous $395,000
48.1%
% of portfolio
0.24%
Previous 0.46%
Shares
16 transactions
Others Institutions Holding ARCT
# of Institutions
169Shares Held
26.2MCall Options Held
2.21MPut Options Held
866K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$34.1 Million0.16% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$19.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.09MShares$15.2 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.03MShares$14.7 Million0.01% of portfolio
-
Nikko Asset Management Americas, Inc.1.95MShares$14.2 Million0.39% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $193M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...